Compounds enzyme inhibitors. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Kidney Myocardium Cells, Cultured Kidney Glomerulus Endothelium, Vascular Cell Line Cell Line, Tumor Heart Liver

Organisms9

Rats, Inbred SHR Rats, Sprague-Dawley Rats, Wistar Rats, Inbred WKY Dogs Digitalis Streptomyces Rabbits Rats, Inbred Strains

Diseases29

Hypertension Angioedema Heart Failure Proteinuria Hyperkalemia Hypertension, Renal Diabetic Nephropathies Kidney Diseases Kidney Failure, Chronic Hypertension, Renovascular Albuminuria Myocardial Infarction Oligohydramnios Cardiac Output, Low Cough Ventricular Dysfunction, Left Disease Models, Animal Chronic Disease Hypertrophy, Left Ventricular Cardiovascular Diseases Hypotension Disease Progression Body Weight Renal Insufficiency Nephrotic Syndrome Diabetes Mellitus, Type 2 Acute Kidney Injury Fibrosis Hypertension, Malignant

Chemicals and Drugs135

Angiotensin-Converting Enzyme Inhibitors Enalapril Captopril Lisinopril Angiotensin Receptor Antagonists Perindopril Enalaprilat Enzyme Inhibitors Antihypertensive Agents Ramipril Angiotensin II Type 1 Receptor Blockers Cilazapril Teprotide Thiazepines Biphenyl Compounds Tetrazoles Renin Diuretics Imidazolidines Adrenergic beta-Antagonists Tetrahydroisoquinolines Losartan 3-Mercaptopropionic Acid Bradykinin Angiotensin II Peptidyl-Dipeptidase A Kinins Angiotensin I Fosinopril Imidazoles Benzimidazoles Saralasin Calcium Channel Blockers Indoles Sulfur Compounds Receptors, Bradykinin Angiotensins Volatile Organic Compounds Aldosterone Sodium Chloride Symporter Inhibitors Cardiovascular Agents Hydrochlorothiazide Hydralazine Benzazepines Receptor, Angiotensin, Type 1 Dipeptides Receptors, Angiotensin Proline Sulfhydryl Compounds Mineralocorticoid Receptor Antagonists Plant Extracts Bicyclo Compounds Amlodipine Protease Inhibitors Spironolactone Oligopeptides Mopidamol Isoquinolines Receptor, Bradykinin B2 Hydroxymethylglutaryl-CoA Reductase Inhibitors Creatinine Cyclohexanones Valine Phenols Benzoates Fumarates Heterocyclic Compounds Small Molecule Libraries Organotin Compounds Phenylmethylsulfonyl Fluoride Aniline Compounds Spiro Compounds Amides Nitrogen Compounds Receptor, Angiotensin, Type 2 Furans Angiotensinogen Bridged Compounds Digoxin Pyridines Receptor, Bradykinin B1 Nitroso Compounds Pyridazines Organometallic Compounds Aspirin Organoselenium Compounds Doxazosin Organophosphorus Compounds Angiotensin II Type 2 Receptor Blockers Azo Compounds Atenolol RNA, Messenger Nitric Oxide Cardiotonic Agents Antineoplastic Agents Neprilysin Aminopeptidases Anti-Inflammatory Agents, Non-Steroidal Cyclooxygenase Inhibitors Thiazoles Anti-Bacterial Agents Epoxy Compounds Furosemide Endothelins Cyclopentanes Indolizines Quaternary Ammonium Compounds Sulfinpyrazone Indapamide Polycyclic Compounds p-Methoxy-N-methylphenethylamine Prodrugs Norepinephrine Endothelin-1 Thiazolidines Benzothiadiazines Hydrocarbons, Aromatic Carbazoles Vasodilator Agents Thiorphan Sodium Kallikreins Sulfonamides Benzyl Compounds Glycopeptides Metalloendopeptidases Organic Chemicals Terphenyl Compounds Receptors, Endothelin Triterpenes Felodipine Pyrazoles Allyl Compounds Indomethacin Pyrimidines

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Blood Pressure Drug Therapy, Combination Drug Evaluation, Preclinical Treatment Outcome Double-Blind Method Magnetic Resonance Spectroscopy Inhibitory Concentration 50 Chromatography, High Pressure Liquid Drug Design Glomerular Filtration Rate Heart Rate Retrospective Studies Risk Factors Nephrectomy Organ Size Disease Models, Animal Randomized Controlled Trials as Topic Follow-Up Studies Prospective Studies Drug Screening Assays, Antitumor Models, Molecular Administration, Oral Gas Chromatography-Mass Spectrometry Diet, Sodium-Restricted Kidney Function Tests Cross-Over Studies High-Throughput Screening Assays Drug Discovery Body Weight Analysis of Variance Stroke Volume Mass Spectrometry Random Allocation Severity of Illness Index Cohort Studies Clinical Trials as Topic

Phenomena and Processes34

Renin-Angiotensin System Blood Pressure Molecular Structure Dose-Response Relationship, Drug Structure-Activity Relationship Time Factors Hemodynamics Inhibitory Concentration 50 Kinetics Glomerular Filtration Rate Stereoisomerism Heart Rate Drug Interactions Renal Circulation Organ Size Drug Synergism Ventricular Function, Left Fermentation Oxidation-Reduction Diet, Sodium-Restricted Volatilization Substrate Specificity Chemical Phenomena Systole Vascular Resistance Binding Sites Body Weight Vasodilation Cell Survival Stroke Volume Hydrogen-Ion Concentration Amino Acid Sequence Protein Binding Molecular Conformation

Disciplines and Occupations4

Drug Design Chemistry Drug Discovery Cardiology

Information Science2

Molecular Sequence Data Amino Acid Sequence

Health Care18

Treatment Outcome Double-Blind Method Retrospective Studies Risk Factors Drug Utilization Review Randomized Controlled Trials as Topic Follow-Up Studies Secondary Prevention Prospective Studies Practice Guidelines as Topic Drug Utilization Guideline Adherence Cross-Over Studies Analysis of Variance Random Allocation Severity of Illness Index Cohort Studies Clinical Trials as Topic

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Angiotensin-Converting Enzyme Inhibitors Enalapril Captopril Lisinopril Angiotensin Receptor Antagonists Perindopril Enalaprilat Enzyme Inhibitors Antihypertensive Agents Ramipril Angiotensin II Type 1 Receptor Blockers Cilazapril Teprotide Renin-Angiotensin System Hypertension Thiazepines Blood Pressure Biphenyl Compounds Tetrazoles Renin Diuretics Imidazolidines Adrenergic beta-Antagonists Tetrahydroisoquinolines Angioedema Losartan 3-Mercaptopropionic Acid Bradykinin Angiotensin II Heart Failure Drug Therapy, Combination Molecular Structure Peptidyl-Dipeptidase A Kinins Proteinuria Dose-Response Relationship, Drug Angiotensin I Fosinopril Imidazoles Kidney Rats, Inbred SHR Benzimidazoles Saralasin Calcium Channel Blockers Indoles Sulfur Compounds Receptors, Bradykinin Hyperkalemia Structure-Activity Relationship Time Factors Angiotensins Volatile Organic Compounds Drug Evaluation, Preclinical Treatment Outcome Aldosterone Sodium Chloride Symporter Inhibitors Cardiovascular Agents Hydrochlorothiazide Hydralazine Hypertension, Renal Benzazepines Receptor, Angiotensin, Type 1 Dipeptides Double-Blind Method Rats, Sprague-Dawley Rats, Wistar Receptors, Angiotensin Magnetic Resonance Spectroscopy Proline Hemodynamics Sulfhydryl Compounds Inhibitory Concentration 50 Diabetic Nephropathies Kidney Diseases Chromatography, High Pressure Liquid Rats, Inbred WKY Mineralocorticoid Receptor Antagonists Plant Extracts Drug Design Bicyclo Compounds Kidney Failure, Chronic Amlodipine Kinetics Protease Inhibitors Spironolactone Oligopeptides Mopidamol Isoquinolines Glomerular Filtration Rate Hypertension, Renovascular Receptor, Bradykinin B2 Hydroxymethylglutaryl-CoA Reductase Inhibitors Creatinine Cyclohexanones Valine Albuminuria Phenols Benzoates Fumarates Heterocyclic Compounds

No FAQ available that match "compounds enzyme inhibitors"